Company News

	5/31/2011	President & CEO Bryan Byong Jin Kim Named as “Global CEO of Korea 2010”
	1/28/2011	VGX International President & CEO Bryan Byong Jin Kim awarded as “The Most Powerful BusinePR_012811ss Leaders in Korea”
	10/27/2010	VGXI supports local Girl Scouts in the 2010 Body Forward™ Challenge
	4/30/2010	VGXI COO Interviewed at INTERPHEX 2010
	3/2/2010	VGXI Expands Manufacturing Facility, Adds Key Personnel
	5/26/09	VGXI Inc. Presents Issues Related to High Concentration, Multi-Component Plasmid Products at the American Society of Gene Therapy 12th Annual Meeting
	12/8/08	GeoVax Labs and VGX International Announce Agreement at the Las Vegas “International Society of DNA Vaccines” Conference
	10/24/08	VGX International signs a Master Product Sale Agreement with BioCancell Therapeutics of Israel to supply plasmid for its multiple clinical programs
	7/3/08	Senesco Chooses VGXI To Produce Factor 5A Plasmid
	5/19/08	VGX announces filings of two separate INDs covering novel DNA vaccines: one for cervical cancer therapy (VGX-3100) and one for avian influenza (VGX-3400)
	5/12/08	VGX signs multi-year production agreement with the United Kingdom Cystic Fibrosis Gene Therapy Consortium
	2/8/08	VGX announces the IND filing of VGX-3200, a novel DNA therapy that utilizes GHRH for the treatment of cancer cachexia and anemia
	2/5/08	VGX announces Initiation of VGX-cGMP Manufactured Plasmid Products in Clinical Use by Partners
	1/9/08	VGX Animal Health announces approval of LifeTide™ SW 5 - World’s First and Only Approved DNA Therapy for Food Animals
	10/29/07	VGX announces an agreement with VGX International to build a large scale cGMP DNA manufacturing plant in Korea
	10/24/07	VGX adds cGMP plasmid DNA manufacturing capacity
	7/11/07	VGX Announces Issuance of Two Key U.S. Patents Covering DNA Plasmid Manufacturing Technology and the Treatment of Anemia

Content on this page requires a newer version of Adobe Flash Player.

Company News